Abstract: Macrophage galactose-type lectin (MGL) participates in the regulation of T cell apoptosis, but the exact death pathway remains unclear. Here, we demonstrated that MGL-induced T cell death occurs in a caspaseindependent manner. Furthermore, MGL treatment triggers the translocation of endonuclease G (EndoG) and apoptosis-inducing factor (AIF) from the mitochondria to the nucleus. Because galectin-1 (Gal-1) can also initiate similar mitochondrial events, we speculate that this death pathway may be widely used by the lectin family.
INTRODUCTION
Inducible T cell apoptosis represents one of the major mechanisms of tumour escape [1] [2] [3] [4] . At least two lectins, galectin-1 (Gal-1) and human macrophage galactose-type lectin (MGL), are involved in regulating T cell death. Gal-1 is a secreted S-type lectin that exhibits β-galactoside binding specificity, and it is distributed in a wide variety of tissues. Additionally, malignant tumours always secrete a large amount of Gal-1 [5, 6] . Accumulating evidence indicates that Gal-1 may specifically regulate T cell survival and function [7] [8] [9] . Gal-1 has also been shown to induce nuclear translocation of endonuclease G (EndoG) in caspase-independent CEM T cell death [10] . Furthermore, MGL is a C-type lectin that exclusively recognizes the GalNAc structure and that is expressed on the surface of immature DCs (iDCs), tolerogenic DCs (tDCs) and macrophages [11] . Glycosylation-dependent interaction of MGL with CD45 on T cells increases T cell death [12] . However, the MGL-induced T cell death pathway remains poorly understood. In this study, we found that MGL induced Jurkat T cell apoptosis via a caspaseindependent pathway, similar to that previously reported in Gal-1-induced T cell death. Moreover, MGL-induced T cell death was accompanied by EndoG and apoptosis-inducing factor (AIF) translocation from the mitochondria to the nucleus. Because Gal-1 initiates similar mitochondrial events, we speculate that this death pathway may be commonly mediated by the lectin family.
MATERIALS AND METHODS

Cell culture
The human T lymphocyte leukaemia cell line Jurkat, the human monocytic leukaemia cell lines THP-1 and U937, the human myelogenous leukaemia cell line KG1, and the human chronic myelogenous leukaemia cell line K562 were maintained in RPMI 1640 medium supplemented with L-glutamine and 10% foetal bovine serum (FBS). The human lung adenocarcinoma epithelial cell line A549 was maintained in DMEM with 10% FBS.
Antibodies and reagents
Antibodies to caspase-3 and AIF were obtained from Cell Signaling Technology (USA). Anti-EndoG was obtained from Santa Cruz (USA). Anti-Gal-1 was obtained from R&D Systems (USA). Recombinant human MGL-Fc was obtained from Sino Biological Inc. (China). Recombinant human Gal-1 was prepared in our laboratory. Etoposide and dithiothreitol (DTT) were obtained from Sigma-Aldrich (USA). Anti-CD3/CD28 beads were obtained from Invitrogen Life Technologies (USA), and enhanced chemiluminescence (ECL) substrate was obtained from GE (USA). The Annexin V-APC/ 7-aminoactinomycin D (7-AAD) Apoptosis Assay Kit was obtained from keyGEN BioTECH (China).
Cell death assays
For Gal-1 death assay, 2 × 10 5 Jurkat cells were cultured in 500 l of complete medium in 24-well plates treated with or without 18 M Gal-1 in the presence of DTT and incubated at 37°C for 24 h. For MGL death assays, 2 × 10 5 Jurkat cells were cultured in 500 l of complete medium in 24-well plates incubated in the presence or absence of MGL (0.8 g/ml) with or without 5 l anti-CD3/CD28 microbeads for 24 h. The cells were then analysed using the Annexin V-APC/7-AAD Apoptosis Assay Kit.
Caspase-mediated apoptosis analysis
A total of 2×10 5 Jurkat cells were treated with 18 M Gal-1 or 0.8 g/ml MGL according to the method describe above. After 24 h, Gal-1-and MGL-treated Jurkat cells were collected and lysed to obtain the whole proteins. Then, the expression of cleaved caspase-3 was analysed via Western blotting.
Immunofluorescence staining
For AIF and EndoG subcellular localization, Gal-1-or MGL-treated Jurkat cells were collected. After fixation and permeabilization, the cells were stained with the anti-AIF and anti-EndoG primary antibodies, as well as their corresponding secondary antibodies. DAPI was used to stain the nuclei. Finally, the cells were mounted onto glass slides and imaged using a laser confocal microscope.
Gal-1 secretion assays
A total of 5×10 6 cells were cultured in RPMI 1640 medium or DMEM without serum for 48 h at 37°C. Subsequently, the cell culture supernatant was collected and concentrated. Then, the samples were analysed for Gal-1 secretion using anti-Gal-1 by Western blotting. Blots were developed by ECL.
RESULTS
MGL induces T cell death in a TCR-dependent manner
In this study, the human T lymphocyte leukaemia cell line Jurkat was selected as an in vitro model for studying T cell apoptosis. We first incubated the recombinant human MGL and Gal-1 proteins separately with Jurkat cells. Then, we measured cell death through staining with annexin-V and 7-AAD by flow cytometry. As shown in Fig. 1 , MGL could induce Jurkat cell apoptosis, and the addition of anti-CD3/CD28 beads clearly enhanced cell apoptosis. In contrast, treatment with anti-CD3/CD28 beads was found to have no additional effects on Gal-1-induced Jurkat cell apoptosis. These results indicated that MGL and Gal-1 significantly induced T cell death in TCR-dependent and TCR-independent manners, respectively.
MGL induces T cell death in a caspase-independent manner
Caspase activation is widely recognized as a key element of the apoptotic process [13] . Caspases normally exist as inactive precursors that are cleaved to give rise to the active form, such as cleaved caspase-3 [14, 15] . As previously reported, Gal-1-induced T cell death is caspase independent [10] . To determine whether MGL-induced T cell death is also caspase independent, we examined cleaved caspase-3 via Western blotting after incubating MGL with Jurkat cells. The activation of procaspase-3, as demonstrated by an increase in the 17-kDa cleavage product after 24 h of treatment, was reflected by etoposide-induced Jurkat cell apoptosis (Fig. 2) . However, MGL-treated Jurkat cells did not show activation of cleaved caspase-3 production (Fig. 2) , suggesting that MGL induces T cell death in a caspase-independent manner. 
MGL induces EndoG and AIF nuclear translocation
Recent new evidence has drawn attention to the emergent role of caspaseindependent cell death pathways [13] . The typical caspase-independent event that occurs during different types of cell death is the translocation of AIF or EndoG from the mitochondria to the nucleus [13, 16] . Therefore, we next examined the subcellular localization of AIF and EndoG using immunofluorescence after the initiation of MGL-mediated apoptosis of Jurkat cells. Consistent with a previous report [10] , Gal-1 induced the nuclear translocation of EndoG, but not AIF (Fig. 3A) . Interestingly, MGL treatment induced both EndoG and AIF translocation from the mitochondria to the nucleus (Fig. 3B) .
MGL acts in concert with Gal-1 to induce T cell death
Because both MGL and Gal-1 regulate T cell apoptosis via caspase-independent mitochondrial events, we examined whether MGL and Gal-1 could together induce T cell apoptosis. As shown in Fig. 4A , treatment with the two lectins yielded more Jurkat cell death than treatment with either lectin alone, indicating that MGL and Gal-1 together contribute to the regulation of T cell survival. To determine whether Jurkat cells are suitable for studying T cell death induced by Gal-1, we measured the capacity of Jurkat cells to secrete Gal-1. Impressively, the several leukaemia cell lines tested (K562, KG-1, THP-1 and U937) secreted Gal-1, whereas Jurkat cells did not (Fig. 4B) .
DISCUSSION
It is well accepted that T cell apoptosis contributes to tumour immune escape. In the last twenty years, many of the relevant studies have focused on the caspasedependent death pathway [15] . However, caspase-independent cell death can occur. Gal-1, a member of the lectin family, has been shown to induce the nuclear translocation of EndoG in caspase-independent CEM T cell death [10] . Recently, another member of the lectin family, MGL, was also shown to mediate T cell death [12] . However, the specific death pathway involved is still unknown. In the present study, we observed nuclear translocation of EndoG and AIF from the mitochondria in MGL-mediated T cell death, which provided another example of caspase-independent cell death. Considering that Gal-1 can also initiate mitochondrial events in caspase-independent T cell apoptosis, we speculated this may represent a common pathway by which lectins induce cell apoptosis. Both MGL and Gal-1 initiate mitochondrial events to induce T cell death, but we noted that the nuclear translocation of AIF upon MGL triggering cannot be observed after incubation with Gal-1. In fact, EndoG and AIF have different functions in the cell apoptosis process. EndoG is an important apoptogenic endonuclease responsible for nucleosomal DNA fragmentation. AIF is believed to induce cell death by triggering chromatin condensation after its nuclear translocation [16] . On the surface of T cells, CD45 is an MGL receptor, while CD7, CD43 and CD45 are Gal-1 receptors [17] . The difference of receptors may explain why MGL and Gal-1 initiate the different mitochondrial events. The precise mechanisms remain to be further elucidated. In humans, monocyte-derived iDCs express moderate MGL levels, which become MGL negative after DC maturation. However, MGL is up-regulated on the surface of tDCs [12] . Interestingly, DCs have been shown to infiltrate many tumours, but tumour-infiltrating DCs from cancer patients appear to be phenotypically and functionally defective and in a state of immaturity and immune tolerance [18] . These findings indicate that tumour-associated DCs express MGL. Recently, alternatively activated macrophages as well as tumour-associated macrophages have also been shown to express high levels of MGL [19, 20] . Additionally, recent evidence demonstrated that tumour cells may impair T cell function by secreting Gal-1, which may tilt the balance towards an immunosuppressive environment [21] . Thus, MGL and Gal-1 most likely coexist in the tumour microenvironment. In the present study, we demonstrated not only that MGL and Gal-1 could each independently induce T cell death but also that combined treatment with both lectins could induce more T cell death than treatment with either alone, indicating that these two lectins additively contribute to the regulation of T cell survival in the tumour microenvironment. The Jurkat cell line has been long and widely used as a model to study T cell functions. However, Jurkat cells are a type of tumour cell. The secretion of Gal-1 has been well documented in many different tumour types, including melanomas, astrocytomas and prostate ovary carcinomas [1, 22, 23] . In the present study, we also selected Jurkat cells as an in vitro T cell model. Therefore, it was necessary to evaluate whether Jurkat cells secrete Gal-1. Our results showed that the several leukaemia cell lines tested (K562, KG-1, THP-1 and U937) secreted Gal-1, whereas Jurkat cells did not, ensuring that Jurkat cells are suitable for studying T cell death induced by Gal-1. Together, these results suggest that our experiments are most likely representative of real physiological conditions. At least in the leukaemia microenvironment, Gal-1 secretion by certain types of malignant leukaemia cells in combination with MGL expression on iDCs and tDCs in leukaemia blood induces T cell apoptosis. In summary, our results demonstrated that MGL can induce nuclear translocation of EndoG and AIF from mitochondria in caspase-independent T cell death. Two lectins, MGL and Gal-1, together contribute to the regulation of T cell survival. Further understanding of the unique pathway of MGL-and Gal-1-induced cell death will be valuable for the development of new approaches to breaking tumour immune tolerance.
